Floatz logo

Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter

Ovarian Carcinosarcoma

Mayo Clinicgene_therapyPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

20 Active assets in the Ovarian Carcinosarcoma cohort.

Asset / SponsorPhaseRating
Carboplatin
University of Oklahoma
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Institute (NCI)
Phase 2BB
Cyclophosphamide
Mayo Clinic
Phase 2BB
Pembrolizumab
Mayo Clinic
Phase 2B
Ifosfamide
GOG Foundation
Phase 3B

View all 35 →

Same molecule, other indications

Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter is also rated in:

primary peritoneal carcinomaDormant
B
Indicative ·
63 / 100
View asset →
fallopian tube serous adenocarcinomaDormant
B
Indicative ·
59 / 100
View asset →
fallopian tube mucinous adenocarcinomaDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →